Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
|
By MedImaging International staff writers Posted on 09 Mar 2021 |

Image: Lunit INSIGHT CXR (Photo courtesy of Lunit)
Philips Healthcare (Amsterdam, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
The agreement is the latest extension of Philips' AI portfolio in precision diagnosis, which leverages this collaboration to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.
Lunit's AI software, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. It accurately detects 10 of the most common findings in a chest X-ray, prioritizes cases with abnormality scores, thereby allows fast triage of normal cases and enables radiologists to focus on reading abnormal cases. The algorithm performs at 97-99% accuracy rate, with its performance validated in major publications such as Radiology, JAMA Network Open, etc.
"For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis," said Daan van Manen, General Manager for Diagnostic X-ray at Philips. "Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact. The high performance of Lunit's AI has been validated in major clinical journals to improve accuracy and efficiency in workflow. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips Radiography Unified User Interface (Eleva), our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow."
"By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base," said Brandon Suh, CEO of Lunit. "With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI."
Related Links:
Philips Healthcare
Lunit
The agreement is the latest extension of Philips' AI portfolio in precision diagnosis, which leverages this collaboration to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.
Lunit's AI software, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. It accurately detects 10 of the most common findings in a chest X-ray, prioritizes cases with abnormality scores, thereby allows fast triage of normal cases and enables radiologists to focus on reading abnormal cases. The algorithm performs at 97-99% accuracy rate, with its performance validated in major publications such as Radiology, JAMA Network Open, etc.
"For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis," said Daan van Manen, General Manager for Diagnostic X-ray at Philips. "Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact. The high performance of Lunit's AI has been validated in major clinical journals to improve accuracy and efficiency in workflow. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips Radiography Unified User Interface (Eleva), our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow."
"By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base," said Brandon Suh, CEO of Lunit. "With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI."
Related Links:
Philips Healthcare
Lunit
Latest Industry News News
- GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
- GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
Channels
Radiography
view channel
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read moreMRI
view channel
International Study Assesses AI for Prostate Cancer MRI Interpretation
Prostate cancer is a leading cause of cancer morbidity in men, and accurate early diagnosis hinges on expert interpretation of prostate magnetic resonance imaging (MRI). Rapid adoption of MRI-first pathways... Read more
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelNew PET Tracer Detects DVT and Pulmonary Embolism in One Scan
Deep vein thrombosis is the formation of clots in deep leg veins that can migrate to the lungs as pulmonary embolism. Rapid confirmation across both regions often requires multiple tests and can delay treatment.... Read more
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read moreGeneral/Advanced Imaging
view channel
AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection
Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read moreNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







